December 6, 2019
December 6, 2019 – The U.S. FDA has approved AvsolaTM (infliximab-axxq), manufactured by Amgen, as a biosimilar for Janssen’s Remicade® (infliximab). It is the fourth Remicade biosimilar to receive FDA approval.
Like Remicade, Avsola is approved to treat certain patients who have rheumatoid arthritis